Evaluating Pilot Implementation of ‘PenCS Flu Topbar’ App in Medical Practices to Improve National Immunisation Program–Funded Seasonal Influenza Vaccination in Central Queensland, Australia

Author:

Khandaker Gulam123ORCID,Chapman Gwenda4,Khan Arifuzzaman56ORCID,Al Imam Mahmudul Hassan17,Menzies Robert8,Smoll Nicolas9,Walker Jacina1,Kirk Michael10,Wiley Kerrie1112

Affiliation:

1. Central Queensland Public Health Unit Central Queensland Hospital and Health Service Rockhampton Queensland Australia

2. Research Division Central Queensland University Rockhampton Queensland Australia

3. Discipline of Child and Adolescent Health, Sydney Medical School The University of Sydney Camperdown New South Wales Australia

4. Herston Biofabrication Institute Metro North Health Herston Queensland Australia

5. Wide Bay Public Health Unit Hervey Bay Hospital and Health Service Hervey Bay Queensland Australia

6. School of Public Health The University of Queensland Herston Queensland Australia

7. School of Health, Medical and Applied Sciences Central Queensland University Rockhampton Queensland Australia

8. Research Division Sanofi Pasteur Canterbury New South Wales Australia

9. Sunshine Coast Public Health Unit Sunshine Coast Hospital and Health Service Maroochydore Queensland Australia

10. Rockhampton Business Unit Central Queensland Hospital and Health Service Rockhampton Queensland Australia

11. Sydney School of Public Health The University of Sydney Camperdown New South Wales Australia

12. Sydney Infectious Diseases Institute The University of Sydney Camperdown New South Wales Australia

Abstract

ABSTRACTBackgroundThe ‘PenCS Flu Topbar’ app was deployed in Central Queensland (CQ), Australia, medical practices through a pilot programme in March 2021.MethodsWe evaluated the app's user experience and examined whether the introduction of ‘PenCS Flu Topbar’ in medical practices could improve the coverage of NIP‐funded influenza vaccinations. We conducted a mixed‐method study including a qualitative analysis of in‐depth interviews with key end‐users and a quantitative analysis of influenza vaccine administrative data.Results‘PenCS Flu Topbar’ app users reported positive experiences identifying patients eligible for NIP‐funded seasonal influenza vaccination. A total of 3606 NIP‐funded influenza vaccinations was administered in the eight intervention practices, 14% higher than the eight control practices. NIP‐funded vaccination coverage within practices was significantly higher in the intervention practices (31.2%) than in the control practices (27.3%) (absolute difference: 3.9%; 95% CI: 2.9%–5.0%; p < 0.001). The coverage was substantially higher in Aboriginal and Torres Strait Islander people aged more than 6 months, pregnant women and children aged 6 months to less than 5 years for the practices where the app was introduced when compared to control practices: incidence rate ratio (IRR) 2.4 (95% CI: 1.8–3.2), IRR 2.7 (95% CI: 1.8–4.2) and IRR 2.3 (1.8–2.9) times higher, respectively.ConclusionsOur evaluation indicated that the ‘PenCS Flu Topbar’ app is useful for identifying the patients eligible for NIP‐funded influenza vaccination and is likely to increase NIP‐funded influenza vaccine coverage in the eligible populations. Future impact evaluation including a greater number of practices and a wider geographical area is essential.

Publisher

Wiley

Reference30 articles.

1. Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017

2. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015

3. Australian Government Department of Health “National Immunisation Strategy for Australia 2019–2024 ”2018.

4. Department of Health and Aged Care “2023 National Immunisation Program Influenza Vaccination—Early Advice for Vaccination Providers ”2023 accessed 2023 https://www.health.gov.au/news/2023‐national‐immunisation‐program‐influenza‐vaccination‐early‐advice‐for‐vaccination‐providers.

5. Influenza vaccination uptake in our most vulnerable groups: how well are we protecting them in 2019?

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3